Solagran (SLA)

Shares / Stock Code


Stock Exchange / Sharemarket


Solagran (SLA) is a Melbourne-based biotechnology company established in 1995 to commercialise a series of natural, biologically active compounds known as Bioeffectives. Developed at the St Petersburg Forest Technical Academy, Bioeffectives have a wide range of therapeutic and disease preventative applications. Solagran’s R&D team is continuing to develop new Bioeffectives, including powerful antioxidants, immunomodulators, antimicrobials and treatments for prostate disorders.

The company was founded in 1995 and listed on the Australian stock market (ASX) in December 1983. Its head office is situated in Melbourne. Over the years the company has provided resouces to the development and testing of Bioeffective R - a Bioeffective comprising polyrenols.

SLA's objective is to commercialise results of a R&D program that commenced in Russia in the 1930s. The focus of this research program has been the extraction and utilisation of the 'live elements' of tree foliage. These substances have been trademarked using the term Bioeffectives. The company's technology permits it to obtain any different Bioeffectives from tree and plant sources.

Since the company concentrates on R&D the company at this stage has minimal customers. Major competitors are other local and international companies involved in researching and developing biologic substances which are aimed at the prevention of diseases.

During the fiscal year ended July 30, 2009 (fiscal 2009), the Company continued clinical studies, research and market development towards the commercialization process of Bioeffectives A, B and R. Its wholly owned subsidiaries include Solathera Limited and Solagran Netherlands BV. SibEx Limited is a 85%-owned subsidiary of the Company.

Solagran (SLA) Products and Services

  • Research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions.

Solagran (SLA) Locations and Subsidiaries

Solagran Head Office
Level 1, 480 St Kilda Road, MELBOURNE,
Phone: (03) 9820 2699
Fax: (03) 9820 3155

Solagran (SLA) Share Price

Submitted by ASX Listed Company on 31 May, 2010 - 14:18